logo

WellPoint a Buy Pre-Earnings - Analyst Blog
By: Zacks Investment Research   Wednesday, January 14, 2009 6:23 PM

Vote for next session
The next market session will close:

WellPoint, Inc. (WLP) is the largest publicly traded commercial health benefits company, in terms of membership in the US. On January 12, 2009, WLP announced that The Centers for Medicare and Medicaid Services (CMS) had suspended the company from enrolling new patients in the health insurance Medicare Advantage plan and the prescription drug benefit, Medicare Part D due to a "sharp" increase in consumer complaints.

We believe the action by CMS is reversible and highlights operational issues that can be addressed by management in the short term. We are presently reviewing our 6-month share price target in light of recent guidance by management however maintain our Buy recommendation at current levels.

WellPoint had been working with CMS to resolve issues identified as a result of internal compliance audits and findings. The decision does not affect current Medicare beneficiaries enrolled in the company's plans. The company also announced it expects to record $349M in net investment losses after taxes for 4Q08. WLP will report 4Q08 financial results on January 28, 2009.


(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Popular Articles
Related Press Releases
Advertisement
Partner Center
Recent Articles by Zacks Investment Research



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia